UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma--a systematic review

PloS one, 2011-02, Vol.6 (2), p.e17127

2011

Volltextzugriff (PDF)

Treatment of neuroblastoma with human natural antibodies

Autoimmunity reviews, 2008-06, Vol.7 (6), p.496-500

Erttmann, Rudolf

2008

Volltextzugriff (PDF)

Second Allogeneic Stem Cell Transplantation in Myeloid Malignancies

Acta haematologica, 2009-01, Vol.122 (4), p.185-192

2009

Volltextzugriff (PDF)

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

The lancet oncology, 2005-09, Vol.6 (9), p.649-658

2005

Volltextzugriff (PDF)

Midkine is highly expressed in neuroblastoma tissues

Pediatric surgery international, 2008-12, Vol.24 (12), p.1355-1359

2008

Volltextzugriff (PDF)

Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival

Pediatric surgery international, 2008, Vol.24 (1), p.101-105

2008

Volltextzugriff (PDF)

Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial

JNCI cancer spectrum, 2021-08, Vol.5 (4)

2021

Volltextzugriff (PDF)

Neuroblastoma Screening at One Year of Age

The New England journal of medicine, 2002-04, Vol.346 (14), p.1047-1053

2002

Volltextzugriff (PDF)

Pretreatment prognostic factors and treatment results in children with hepatoblastoma: A report from the German Cooperative Pediatric Liver Tumor Study HB 94

Cancer, 2002-07, Vol.95 (1), p.172-182

2002

Volltextzugriff (PDF)

Ligands for the peroxisome proliferator-activated receptor-γ have inhibitory effects on growth of human neuroblastoma cells in vitro

Toxicology (Amsterdam), 2005-09, Vol.213 (1), p.157-168

2005

Volltextzugriff (PDF)

Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans

Nature medicine, 1996-06, Vol.2 (6), p.686-689

1996

Volltextzugriff (PDF)

Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors

Experimental hematology, 2008-08, Vol.36 (8), p.1047-1054

2008

Volltextzugriff (PDF)

L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors

Annals of surgical oncology, 2007-12, Vol.14 (12), p.3575-3580

2007

Volltextzugriff (PDF)

Outcome of HLA-Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation Depends On the Intensity of the Conditioning Regimen

Blood, 2009-11, Vol.114 (22), p.3393-3393

2009

Volltextzugriff (PDF)

Comparable Results of HLA-Mismatched Vs HLA-Matched Unrelated Donors for Allogeneic Stem Cell Transplantation Using Pre-Transplant ATG

Blood, 2008-11, Vol.112 (11), p.966-966

2008

Volltextzugriff (PDF)

Second Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Blood, 2008-11, Vol.112 (11), p.4308-4308

2008

Volltextzugriff (PDF)

Dose‐reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia

British journal of haematology, 2002-12, Vol.119 (3), p.769-772

2002

Volltextzugriff (PDF)

Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany

Cancer letters, 2003-07, Vol.197 (1), p.19-28

2003

Volltextzugriff (PDF)

Faster Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation of Younger Children Compared with Older Children and Adults

Blood, 2004-11, Vol.104 (11), p.1250-1250

2004

Volltextzugriff (PDF)

Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single‐centre experience of 12 patients

British journal of haematology, 1999-09, Vol.106 (4), p.1052-1058

1999

Volltextzugriff (PDF)

Lead-time and overdiagnosis estimation in neuroblastoma screening

Statistics in medicine, 2003-09, Vol.22 (18), p.2877-2892

2003

Volltextzugriff (PDF)

Normal Human Serum Contains a Natural IgM Antibody Cytotoxic for Human Neuroblastoma Cells

Proceedings of the National Academy of Sciences - PNAS, 1996-04, Vol.93 (9), p.4498-4503

1996

Volltextzugriff (PDF)

Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma

Cancer chemotherapy and pharmacology, 1989, Vol.24 (6), p.376-380

1989

Volltextzugriff (PDF)

Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany: Neuroblastoma - Developmental and molecular biology meet therapy design

Cancer letters, 2003, Vol.197 (1-2), p.19-28

2003

Volltextzugriff (PDF)

Pretreatment prognostic factors and treatment results in children with hepatoblastoma

Cancer, 2002-07, Vol.95 (1), p.172-182

2002

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(36)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma--a systematic review

Treatment of neuroblastoma with human natural antibodies

Second Allogeneic Stem Cell Transplantation in Myeloid Malignancies

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

Midkine is highly expressed in neuroblastoma tissues

Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival

Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial

Neuroblastoma Screening at One Year of Age

Pretreatment prognostic factors and treatment results in children with hepatoblastoma: A report from the German Cooperative Pediatric Liver Tumor Study HB 94

Ligands for the peroxisome proliferator-activated receptor-γ have inhibitory effects on growth of human neuroblastoma cells in vitro

Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans

Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors

L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors

Outcome of HLA-Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation Depends On the Intensity of the Conditioning Regimen

Comparable Results of HLA-Mismatched Vs HLA-Matched Unrelated Donors for Allogeneic Stem Cell Transplantation Using Pre-Transplant ATG

Second Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Dose‐reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia

Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany

Faster Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation of Younger Children Compared with Older Children and Adults

Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single‐centre experience of 12 patients

Lead-time and overdiagnosis estimation in neuroblastoma screening

Normal Human Serum Contains a Natural IgM Antibody Cytotoxic for Human Neuroblastoma Cells

Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma

Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany: Neuroblastoma - Developmental and molecular biology meet therapy design

Pretreatment prognostic factors and treatment results in children with hepatoblastoma

Aktive Filter

Suchergebnisse filtern